This approach has been designed to determine the maximum suggested starting dose, even though lower starting doses may also be suitable in some first-in-human clinical trials
It is not a substrate, inhibitor, or inducer of CYP1A2, CYP2C9, CYP2C19, CYP2D6, or CYP3A4
For example, a national study found that caregivers of people with dementia who had a diagnosis of diabetes or osteoporosis were 2.6 and 2.3 times more likely, respectively, to report emotional difficulties with care compared with caregivers of people with dementia who did not have these cooccurring conditions
Not dosing advice and not for human or animal administration
Anti-Inflammatory Action: GHK-Cu exhibits potent anti-inflammatory properties by modulating cytokine expression, suppressing the activity of pro-inflammatory signals like NF-B and TNF-alpha
Mixing can cause degradation or altered bioavailability